FURTHER EVIDENCE FOR THE LACK OF ASSOCIATION BETWEEN ACETYLATOR PHENOTYPE AND SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：19
作者：
BAER, AN
WOOSLEY, RL
PINCUS, T
机构：
[1] VANDERBILT UNIV, DEPT MED, DIV RHEUMATOL & IMMUNOL, NASHVILLE, TN 37240 USA
[2] VANDERBILT UNIV, DEPT PHARMACOL, DIV CLIN PHARMACOL, NASHVILLE, TN 37240 USA
[3] VET ADM MED CTR, NASHVILLE, TN 37203 USA
来源：
ARTHRITIS AND RHEUMATISM | 1986年 / 29卷 / 04期
关键词：
D O I：
10.1002/art.1780290408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：508 / 514
页数：7
相关论文
共 34 条
[1]   ISONIAZID ACETYLATION RATE AND DEVELOPMENT OF ANTINUCLEAR ANTIBODIES UPON ISONIAZID TREATMENT [J].
ALARCONSEGOVIA, D ;
FISHBEIN, E ;
ALCALA, H .
ARTHRITIS AND RHEUMATISM, 1971, 14 (06) :748-+
[2]   INDIVIDUAL-DIFFERENCES IN DISPOSITION OF DRUGS METABOLIZED IN BODY [J].
ALVAN, G .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :155-175
[3]  
CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[4]   GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN NEGRO + JAPANESE POPULATIONS [J].
DUFOUR, AP ;
KNIGHT, RA ;
HARRIS, HW .
SCIENCE, 1964, 145 (363) :391-&
[5]  
DURANT PJ, 1980, NEW ENGL J MED, V303, P584
[6]   HEPATIC DRUG ACETYLATION AND OXIDATION - EFFECTS OF AGING IN MAN [J].
FARAH, F ;
TAYLOR, W ;
RAWLINS, MD ;
JAMES, O .
BRITISH MEDICAL JOURNAL, 1977, 2 (6080) :155-156
[7]  
FISHBEIN E, 1976, ARTHRITIS RHEUM, V19, P796
[8]  
Fishbein E, 1979, Arthritis Rheum, V22, P95, DOI 10.1002/art.1780220118
[9]   ACETYLATOR PHENOTYPE IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FOAD, B ;
LITWIN, A ;
ZIMMER, H ;
HESS, EV .
ARTHRITIS AND RHEUMATISM, 1977, 20 (03) :815-818
[10]  
HANNGREN A, 1970, SCAND J RESPIR DIS, V51, P61
1234